Curibio Leverages Their 3D Neuromuscular Junction Model for Botox Potency Assay in Collaboration with Genetox and DreamCIS

Latest collaboration news on portfolio company Curi Bio. Curi Bio’s preclinical discovery platform combines human stem cells, systems, and data to accelerate the discovery of new medicines. The Curi Engine is a seamless, bioengineered platform that integrates human iPSC-derived cell models, tissue-specific biosystems, and A.I./M.L.-enabled phenotypic screening data